Additional markers not included in the MSIS criteria, such as serum ELA–2, BPI, procalcitonin, synovial CRP, calprotectin, and molecular techniques like PCR present promising diagnostic values for the diagnosis of PJI, but more studies are needed to confirm their efficacy for patients with IA. This evidence concerns the gene CRP and juvenile polyposis syndrome.